Analysts Set Celldex Therapeutics, Inc. (NASDAQ:CLDX) Price

Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average […]

Related Keywords

Wellington , New Zealand General , New Zealand , Dekabank Deutsche Girozentrale , Celldex Therapeutics Inc , Wellington Management Group , Capital Partners , Charles Schwab Investment Management Inc , Panoramic Investment Advisors , Celldex Therapeutics , Cantor Fitzgerald , Nasdaq , Celldex Therapeutics Company Profile , Get Free Report , Marketbeat Ratings , Management Group , Bank Deutsche Girozentrale , Schwab Investment Management , Get Free , Celldex Therapeutics Daily ,